FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

116 letters match. Newest first.

  1. Conroe Welding Supply, Inc.

    FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).

    High risk
  2. Pritam International Private Limited

    Pritam International, an Indian OTC drug maker, was cited for CGMP violations, falsified lab data, unsafe color additive, and DEG/EG testing gaps.

    High risk
  3. Lovelace Biomedical Research Institute

    Lovelace Biomedical's quality unit failed to ensure final drug study reports matched raw data, FDA says.

    Medium
  4. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  5. Pine Pharmaceuticals, LLC

    FDA cited outsourcing facility Pine Pharmaceuticals in Tonawanda, NY, for insanitary sterile compounding conditions and CGMP failures after a November 2025 inspection.

    High risk
  6. DeJong Family Dairy, LLC

    FDA warned DeJong Family Dairy that it treated cows with an animal drug in ways the label and a veterinarian did not allow.

    Medium
  7. Shimoga Chemicals

    FDA warns Shimoga Chemicals of manufacturing quality and data integrity failures in clomiphene citrate active ingredient.

    High risk
  8. 3B Medical, Inc. dba Reach Health, Inc.

    FDA warns Reach Health over unapproved APAP use change and complaint/CAPA failures.

    High risk
  9. Aversa's Italian Bakery

    FDA warns Aversa's Italian Bakery over missing food safety plan and undeclared sesame/milk allergens in ready-to-eat rolls.

    High risk
  10. HealthPartners Neuroscience Center Research and Innovation

    FDA warned HealthPartners Neuroscience Center that its animal studies of an investigational drug violated good laboratory practice rules.

    Medium
  11. City Market, Inc.

    FDA cited City Market, Inc. for insanitary conditions and seafood safety plan (HACCP) failures involving ready-to-eat pasteurized canned crab meat.

    High risk
  12. Lexia LLC

    FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.

    High risk
  13. Pro Numb Tattoo Numbing Spray, LLC

    FDA cited Pro Numb Tattoo Numbing Spray for selling unapproved, misbranded numbing drugs and manufacturing quality failures after a November 2025 inspection.

    High risk
  14. Schlechter Farms Inc.

    FDA found bird feces throughout Schlechter Farms' Oregon onion packing shed, adulterating onions and repeating 2023 violations.

    High risk
  15. Microbiological Testing & Consulting, LLC

    FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.

    High risk
  16. Exactech, Inc. dba Advita Ortho

    FDA warned Exactech/Advita Ortho over quality-system failures in Equinoxe shoulder implants found during a July 2025 Sarasota inspection.

    High risk
  17. Bertrand P. Cole, D.O.

    FDA warns Dr. Bertrand P. Cole that he gave four trial subjects too much drug by not following the study plan.

    High risk
  18. Mark S. Dacey, M.D.

    FDA warns Dr. Mark S. Dacey that a trial subject underwent an optional eye-fluid sampling procedure after twice declining consent.

    High risk
  19. Maui Seafood LLC

    Maui Seafood LLC's Las Vegas RTE tuna and salmon plant had Listeria monocytogenes (a harmful bacterium) and seafood safety plan sanitation violations.

    High risk
  20. Palamur Biosciences Private Limited

    FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.

    High risk
  21. Microvascular Tissue, Inc.

    FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.

    High risk
  22. Bedner Growers, Inc.

    FDA: Bedner Growers' cucumbers tied to Salmonella outbreaks; packing line and product tested positive.

    High risk
  23. DeVere Manufacturing Inc.

    FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.

    High risk
  24. Delicias Del Country USA Inc

    Delicias Del Country USA, a Laredo, Texas food importer, had no Foreign Supplier Verification Program for imported cakes and pastries.

    Medium
  25. SeniorLife Technologies, Inc.

    FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.

    High risk
  26. Jiangsu Kerbio Medical Technology Group Co.

    FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.

    High risk
  27. CCIC Huatongwei International Inspection Co., Ltd.

    FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.

    High risk
  28. Les Encres LLC

    FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.

    High risk
  29. Spectra Therapy, LLC

    FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.

    High risk
  30. Xtreme Tools International, Inc.

    FDA warned Xtreme Tools International after an inspection found manufacturing-rule failures for OTC topical drugs, including missing ingredient and batch testing.

    High risk
  31. Peter Michael, M.D.

    FDA warns clinical investigator Peter Michael, M.D. that pediatric trial subjects received twice the protocol's maximum drug dose.

    High risk
  32. Healwell Homeo Private Limited

    FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.

    High risk
  33. Staska Pharmaceuticals, Inc.

    FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.

    High risk
  34. United King Foods Private Limited

    FDA warned United King Foods over serious low-acid canned food processing violations for Gulab Jamun exported to the U.S.

    High risk
  35. Wailea Agricultural Group, Inc.

    Wailea Agricultural Group's hearts of palm were adulterated after FDA found E. coli in water used for handwashing and cleaning.

    High risk
  36. Kabe Labortechnik GmbH

    Kabe Labortechnik lacked validated processes and design controls for SAFE-T-FILL blood collection tubes, FDA found.

    High risk
  37. BioAsia Worldwide Sdn Bhd

    FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.

    High risk
  38. EpiCare Acquisitions, LLC

    FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.

    High risk
  39. Yangzhou Sion Commodity Co., Ltd.

    FDA warned Yangzhou Sion Commodity over drug manufacturing failures, including untested high-risk ingredients and unreliable lab records.

    High risk
  40. Exer Labs, Inc.

    Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.

    High risk
  41. Rite-Kem Incorporated

    FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.

    High risk
  42. Chem-Tech, Ltd.

    Chem-Tech, Ltd. lacked adequate investigations and clean equipment for its OTC drug.

    High risk
  43. ABR Laboratory LLC

    FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.

    High risk
  44. Miyajima Shoyu Co., Ltd.

    Miyajima Shoyu lacked FDA-filed scheduled processes for acidified Wasabi Dressing, making it adulterated.

    High risk
  45. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  46. Agustson A/S

    Agustson A/S exported acidified seaweed caviar to the US without following filed scheduled processes and process controls.

    High risk
  47. Advance Nature Sdn Bhd

    FDA warns Malaysia's Advance Nature over inadequate heat-process controls for exported low-acid bamnut milk.

    High risk
  48. Richard W. Foltin, Ph.D.

    FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.

    High risk
  49. Namita A. Goyal, M.D.

    FDA warned clinical investigator Dr. Namita Goyal over a biologic trial that enrolled ineligible subjects and kept poor records.

    High risk
  50. Hemarus LLC

    Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.

    High risk